Analysis of the success rates of new drug development in Japan and the lag behind the US-Reference-Cited by-同舟云学术

Analysis of the success rates of new drug development in Japan and the lag behind the US

Published:2012-03 Issue:3 Volume:104 Page:241-246
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Hirai Yuka,Yamanaka Yosuke,Kusama Makiko,Ishibashi Taro,Sugiyama Yuichi,Ono Shunsuke

Publisher

Elsevier BV

Subject

Health Policy

Reference15 articles.

1. Trends in risks associated with new drug development: success rates for investigational drugs;DiMasi;Clinical Pharmacology and Therapeutics,2010

2. The price of innovation: new estimates of drug development costs;DiMasi;Journal of Health Economics,2003

3. O’Hagan P, Farkas C. Bringing pharma R&D back to health. Bain Brief 2009. Available from: http://www.bain.com/bainweb/PDFs/cms/Public/BB_Managing_RandD_HC.pdf.

4. Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances;Danzon;Journal of Health Economics,2005

5. Follow the leader;Tsuji;Nature,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug safety and pharmaceutical regulation in the age of global development;Translational and Regulatory Sciences;2020

2. Survey of Japanese Orphan Drug Program: Factors Related to Successful Marketing Approval;The Journal of Clinical Pharmacology;2019-07-31

3. A Significant Anticancer Drug Approval Lag Between Japan and the United States Still Exists for Minor Cancers;Clinical Pharmacology & Therapeutics;2018-07-22

4. Utilization of the Bridging Strategy for the Development of New Drugs in Oncology to Avoid Drug Lag;The Journal of Clinical Pharmacology;2017-06-19

5. 1. The Roles of Pharmaceutical Regulation and Information in Creating and Fostering New Drugs;Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics;2016